PARIS, DECEMBER 14, 2023 | Kreussler Pharma – Chemische Fabrik Kreussler & Co. GmbH and S.T.D. Pharmaceutical Products Ltd. announced their collaboration on the worldwide production, marketing, and distribution of Fibrovein during Kreussler’s sponsored symposium at the 81st annual congress of the French Society of Phlebology.
Céline Eggen: Little Atlas of Phlebology
This practical atlas contains simple illustrations, with short and understandable descriptions, covering the most common disorders and treatments within the field of phlebology.
The atlas is aimed at supporting patient education in the consulting room. The wire-o bond makes it easily possible to only demonstrate the illustration. Due to the accompanying texts, the book is also suitable for patients themselves to read, in the waiting room or at home.
The atlas can also be read as a short introduction into phlebology.
A5 size, wire-o bond with soft cover, fully foldable, 66 pages, 29 color illustrations, solid pages (200g) with water-repellent properties
More information: www.atlasofphlebology.com/
For the first time since the introduction of the Coronavirus-restrictions in March 2020, Kreussler Pharma was able to take part in a conference again. From 2-5 September, the 62nd Annual Conference of the German Society of Phlebology in Leipzig was one of the first medical conferences to be allowed to take place on site since the lockdown. Despite the strict hygiene regulations including mandatory face covering, some 700 participants met in excellent conditions for the important personal exchange with opinion leaders and experts — an opportunity welcomed by Kreussler managing director Dr. Stephan Travers: “It really feels great to be back on a conference site and to finally talk to everyone face to face”, he described the good atmosphere in an interview with the conference organiser
Thanks to conference chair Dr. Tobias Hirsch, the conference also had an international orientation for the first time, which was particularly evident in the joint session on sclerotherapy by the French and German societies of phlebology. Due to travel restrictions, certain international speakers, e.g. from the US or France had to join online instead of in person, which, thanks to modern technology, did not reduce the quality of the discussions after the speeches. In addition, about 200 enthusiasts from 24 countries joined the mostly fully booked speeches and workshops via livestream. Despite — or possibly even because of — the strict, but well conceived health protection measures, the conference was an all-round success for Kreussler.
Focus on (foam) sclerotherapy of hemorrhoidal disease
First international expert meeting at Kreussler's headquarter in Wiesbaden
Sclerotherapy with liquid Aethoxysklerol has been used successfully for the treatment of hemorrhoidal disease since 1966. Whereas foam sclerotherapy has been proved as an effective treatment option for varicose veins for years, it was as late as 2006 when first studies in the treatment of hemorrhoidal disease with foam were started in ltaly and Germany. However, the ltalian method using a flexible endoscope turned out to be too complex and cost-intensive. The method using a proctoscope that has been developed by Dr. Moser from Germany, was picked up in ltaly only in 2015 and then further evaluated in several clinical studies. The latter ltalian activity caused a real boom in sclerotherapy.
For this reason Kreussler Pharma, as the world's leading manufacturer of sclerosants, has initiated this first meeting focusing on hemorrhoidal disease with key opinion leaders from Germany, ltaly, and Poland. The aim of the meeting was to find a consensus on the most important issues in the field of sclerotherapy. On the 18th of January 2020, in the conference rooms of Kreussler, the experts discussed and summarized essential diagnostic measures and the best sclerotherapy techniques. In the afternoon, the experts introduced their experiences with foam
